טוען...
Dual activities of ritanserin and R59022 as DGKα inhibitors and serotonin receptor antagonists
Diacylglycerol kinase alpha (DGKα) catalyzes the conversion of diacylglycerol (DAG) to phosphatidic acid (PA). Recently, DGKα was identified as a therapeutic target in various cancers, as well as in immunotherapy. Application of small-molecule DGK inhibitors, R59022 and R59949, induces cancer cell d...
שמור ב:
| הוצא לאור ב: | Biochem Pharmacol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5164959/ https://ncbi.nlm.nih.gov/pubmed/27974147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2016.10.011 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|